Foamix Pharmaceuticals (FOMX) Management Meetings Show Pipeline on Track - Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $30.00 price target on Foamix Pharmaceuticals (NASDAQ: FOMX) after KOL checks ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
